ArticleCureus2026
Dermatomyositis With Necrotizing Vasculitis, Pulmonary Arterial Hypertension, and Extensive Calcinosis Following Delayed Diagnosis.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dermatomyositis is a rare autoimmune inflammatory disease with a highly heterogeneous clinical presentation and potential for multisystem involvement. Early diagnosis may be challenging, particularly in patients presenting with amyopathic disease and limited initial laboratory abnormalities. We report the case of a 45-year-old woman initially diagnosed with amyopathic dermatomyositis based on characteristic cutaneous manifestations in the absence of objective muscle involvement on laboratory testing and electromyography. After being lost to follow-up for four years, she presented with progressive proximal muscle weakness, extensive ulcerative calcinosis, Raynaud phenomenon, and exertional dyspnea. Extended myositis serology revealed anti-Mi-2 and anti-signal recognition particle (SRP) antibodies. Muscle biopsy demonstrated perifascicular atrophy, necrotizing vasculitis, and foreign-body granulomatous inflammation associated with dystrophic calcinosis. Right heart catheterization confirmed pre-capillary pulmonary arterial hypertension in the absence of interstitial lung disease. The patient was treated with intravenous cyclophosphamide, pulmonary vasodilator therapy, colchicine, and tapering corticosteroids, resulting in clinical and functional improvement. This case highlights the potential progression of initially amyopathic dermatomyositis to severe systemic disease, the limitations of isolated serological assessment, and the importance of long-term follow-up. It also illustrates several uncommon manifestations of adult dermatomyositis, including extensive calcinosis, pulmonary arterial hypertension, and histologically proven necrotizing vasculitis, supporting the concept of dermatomyositis as a systemic vasculopathic disorder.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.